Putnam BioRevolution ETF (SYNB)
Putnam BioRevolution ETF operates in the Asset Management industry of the Financial Services sector, headquartered in San Mateo, CA, US. The stock last traded at $31.61, down 0.37% on the session, giving a market capitalisation of $5.3M. Its beta of 1.07 implies it has historically moved more than the broad market.
This exchange-traded fund (ETF) primarily allocates its capital to common equity securities issued by companies globally, irrespective of their market capitalization. Its central investment theme revolves around enterprises driving the "biology revolution," whether they are classified as growth-oriented, value-based, or a blend of both. Periodically, the fund may dedicate a substantial segment of its assets to firms operating within one or more interconnected industries or sectors. These could encompass areas such as healthcare, consumer discretionary, consumer staples, biotechnology, and materials. As a non-diversified fund, its portfolio may exhibit higher concentration.
Putnam BioRevolution ETF is most often compared with the following Financial Services names: